Nektar Therapeutics (NKTR)
80.45
+2.95
(+3.81%)
USD |
NASDAQ |
Apr 13, 16:00
80.50
+0.05
(+0.06%)
Pre-Market: 08:35
Nektar Therapeutics Cash from Investing (TTM) : -1.197M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Boston Scientific Corp. | -2.64B |
| Soleno Therapeutics, Inc. | -201.78M |
| Eli Lilly & Co. | -10.97B |
| Regeneron Pharmaceuticals, Inc. | -629.10M |
| Esperion Therapeutics, Inc. | 0.00 |